Biotech in Countries Starting with 'I' – Part 5
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? […]
General Biotechnology
General Biotechnology
Human cell- and tissue- based products: Progress, promise and regulatory issues
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Human cell- and tissue- based products: Progress, promise and regulatory issues
Go to paperABSTRACT: The field of cell- and tissue-based products is radical…
Human cell- and tissue- based products: Progress, promise and regulatory issues Read Post »
General Biotechnology
Fourth Edition of Building Biotechnology now Available
The fourth edition of Building Biotechnology, the premier biotechnology industry primer, is now available. Building Biotechnology has been adopted by dozens of
Fourth Edition of Building Biotechnology now Available Read Post »
General Biotechnology
Embryo and stem cell research: Views from the USA
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Embryo and stem cell research: Views from the USA
Go to paperABSTRACT: Presents a study that examined the history, ethical debates and religious views rega…
Embryo and stem cell research: Views from the USA Read Post »
General Biotechnology, Guest content
Is the Research Enterprise in Decline? (Part 2)
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
General Biotechnology
Internship opportunities at BiotechBlog.com
With prior BiotechBlog intern Fintan Burke moving on to some exciting new projects, I have time to train a few
General Biotechnology
New book by biotechnology pioneer Ananda Chakrabarty
Ananda Chakrabarty is the holder of the first patent on a genetically-modified organism. Lately he’s turned his sights to a
New book by biotechnology pioneer Ananda Chakrabarty Read Post »
General Biotechnology
Cancer remains the dominant disease target for biotech through to 2010
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Cancer remains the dominant disease target for biotech through to 2010
Go to paperABSTRACT: The two leading therapeutic areas for biological products, in t…
Cancer remains the dominant disease target for biotech through to 2010 Read Post »
General Biotechnology
Fourth edition of Building Biotechnology coming soon
The fourth edition of Building Biotechnology, the premier biotechnology industry primer, is slated for publication in December and is ready for reviewers.
Fourth edition of Building Biotechnology coming soon Read Post »
General Biotechnology
Miscasting Patent Linkage
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
